Tumor News and Research

RSS

Liquid biopsy could better predict immunotherapy response in lung cancer patients than tumor biopsy

Mount Sinai researchers have validated for the first time that a simple blood test called a liquid biopsy could be a better predictor of whether cancer immunotherapy will be successful for a patient with lung cancer than an invasive tumor biopsy procedure.

3 Jun 2022

Counting metastatic lymph nodes is better for determining prognoses of solid tumors

Patients newly diagnosed with cancer typically focus on one question, eclipsing all others: "What is my prognosis?"

2 Jun 2022

MD Anderson and National Resilience launch the Cell Therapy Manufacturing Center

The University of Texas MD Anderson Cancer Center and National Resilience, Inc., today announced the launch of a joint venture, the Cell Therapy Manufacturing Center, to accelerate the development and manufacturing of innovative cell therapies for patients with cancer.

2 Jun 2022

Scientists identify a new pneumococcal vaccine candidate

Researchers at Karolinska Institutet in Sweden have identified a new vaccine candidate against pneumococci, bacteria that can cause pneumonia, sepsis, and meningitis.

2 Jun 2022

Aerobic exercise amplifies the effects of immunotherapy to reduce pancreatic tumor growth

Aerobic exercise reprograms the immune system to reduce pancreatic tumor growth and amplify the effects of immunotherapy, a new study finds.

2 Jun 2022

Substances touted to improve athletic performance and high fat diet fuel pancreatic cancer’s development

Researchers at the University of Michigan Rogel Cancer Center have found a cell nuclear receptor activated by high fat diets and synthetic substances in unregulated athletic performance enhancers fuels the progression of precancerous pancreas lesions into pancreatic cancer.

1 Jun 2022

New "masked" version of immunotherapy could help fight cancer without causing side effects

Many cancer treatments are notoriously savage on the body; they attack healthy cells at the same time as tumor cells, causing a plethora of side effects.

1 Jun 2022

New research may open a window to treating aggressive form of B-cell acute lymphoblastic leukemia

Survival has improved greatly in children with acute lymphocytic leukemia (ALL). But a certain form of ALL that occurs mostly in babies is still very lethal, with a survival rate below 50 percent: B-cell acute lymphoblastic leukemia with rearrangements of the mixed lineage leukemia gene, or MLL B-ALL.

1 Jun 2022

Genetically modified herpes virus can be used in the fight against cancer

Viruses can make animals and humans sick - or healthy: Researchers at the Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB have succeeded in genetically modifying the herpes simplex virus type 1, which triggers painful cold sores, in such a way that it can be used in the fight against cancer in the future.

1 Jun 2022

Study finds a link between aging and cancer metastases

Spreading cancer cells that escape a primary tumor site can seed in tissues distant from the tumor, but may take several years or decades to grow into full metastatic cancers.

1 Jun 2022

UCLA researchers identify a method to make tumors susceptible to immune attack

One powerful way cancer cells defend against tumor-killing immune cells is to load up their cell surface with a protein known as PD-L1. Now a team of UCLA Jonsson Comprehensive Cancer Center researchers led by Roger S. Lo, MD, PhD, has identified a method to degrade tumor cell-surface PD-L1, thereby making tumors susceptible to immune attack.

31 May 2022

Liver4Life research team treated damaged liver in a machine and then implanted the recovered organ

The multidisciplinary Zurich research team Liver4Life has succeeded in doing something during a treatment attempt that had never been achieved in the history of medicine until now: it treated an originally damaged human liver in a machine for three days outside a body and then implanted the recovered organ into a cancer patient.

31 May 2022

Tumor News and Research

Liquid biopsy could better predict immunotherapy response in lung cancer patients than tumor biopsy

Counting metastatic lymph nodes is better for determining prognoses of solid tumors

MD Anderson and National Resilience launch the Cell Therapy Manufacturing Center

Scientists identify a new pneumococcal vaccine candidate

Aerobic exercise amplifies the effects of immunotherapy to reduce pancreatic tumor growth

Substances touted to improve athletic performance and high fat diet fuel pancreatic cancer’s development

New "masked" version of immunotherapy could help fight cancer without causing side effects

New research may open a window to treating aggressive form of B-cell acute lymphoblastic leukemia

Genetically modified herpes virus can be used in the fight against cancer

Study finds a link between aging and cancer metastases

UCLA researchers identify a method to make tumors susceptible to immune attack

Liver4Life research team treated damaged liver in a machine and then implanted the recovered organ

Scientists develop new way to attack synovial sarcoma using an investigational drug

New discovery could pave the way for more effective cancer immunotherapy

New compounds for cancer immunotherapy via STING-mediated immune activation

Renowned pharmaceutical scientist will collaborate with JGU professor to reduce side effects of chemotherapy

Novel photonic technology could enable fluorescent sensors to track molecules deep inside the body

New approach to quantify cognitive decline in dogs could aid in the treatment of humans with Alzheimer’s

First-of-its-kind platform generates antitumor immunity and improves responses to checkpoint inhibitors

Researchers reveal a possible biological mechanism connecting breast cancer and type 2 diabetes

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News